# Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/semaglutide-versus-dulaglutide-once-weekly-in-patients-with-type-2-diabetes/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Richard E. Pratley,Vanita R. Aroda,Ildiko Lingvay,J Lüdemann,Camilla Andreassen,Andrea Navarria,Adie Viljoen |
| Citations | 778 |
| DOI | 10.1016/s2213-8587(18)30024-x |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2787255324 |
| PMID | 29397376 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Richard E. Pratley](https://scholariq.org/researchers/richard-e-pratley/)
- [Ildiko Lingvay](https://scholariq.org/researchers/ildiko-lingvay/)

## Paper journal

- [The Lancet Diabetes & Endocrinology](https://scholariq.org/journals/the-lancet-diabetes-and-endocrinology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.